NCT06992362View on ClinicalTrials.gov

Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Hepatoid Adenocarcinoma of Stomach
Interventions
DRUG

Perioperative treatment

RC48+SOX+Sindilizumab

Trial Locations (1)

Unknown

RECRUITING

Peking University Cancer Hospital & Institute, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER